<p>In a recent study, the risk for subdural hematoma was greatest when antithrombotic medications were combined, especially with warfarin/antiplatelet combinations.</p>

Antithrombotics and Subdural Risk

May 1, 2017

In a recent study, the risk for subdural hematoma was greatest when antithrombotic medications were combined, especially with warfarin/antiplatelet combinations.

Issue Date: May 1, 2017

Table of Contents

Financial Disclosure: To reveal any potential bias in this publication, and in accordance with Accreditation Council for Continuing Medical Education guidelines, Dr. Brunton reports he is a retained consultant for Abbott Diabetes, Actavis, AstraZeneca, Becton Dickinson, Boehringer Ingelheim, Cempra, Janssen, Lilly, Merck, Novo Nordisk, Sanofi, and Teva; he serves on the speakers bureau of AstraZeneca, Boehringer Ingelheim, Janssen, Lilly, Novo Nordisk, and Teva. Dr. Kuritzky (author) is a retained consultant for and on the speakers bureau of Allergan, Daiichi Sankyo, Lilly, and Lundbeck. Ms. Coplin and Mr. Springston report no financial relationships relevant to this field of study.

Subscription Publication Books & Study Guides Group & Site Licenses State CME/CE Requirements